| Literature DB >> 30365985 |
Bo Shen1, Gursimran Kochhar2, Udayakumar Navaneethan3, Xiuli Liu4, Francis A Farraye5, Yago Gonzalez-Lama6, David Bruining7, Darrell S Pardi7, Martin Lukas8, Martin Bortlik8, Kaicun Wu9, Ajit Sood10, David A Schwartz11, William J Sandborn12.
Abstract
Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30365985 DOI: 10.1016/j.gie.2018.09.045
Source DB: PubMed Journal: Gastrointest Endosc ISSN: 0016-5107 Impact factor: 9.427